tiprankstipranks
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE

Ultragenyx Pharmaceutical (RARE) Technical Analysis

580 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Ultragenyx Pharmaceutical’s (RARE) Moving Averages Convergence Divergence (MACD) indicator is -0.63, suggesting Ultragenyx Pharmaceutical is a Buy.
Ultragenyx Pharmaceutical’s (RARE) 20-Day exponential moving average is 47.44, while Ultragenyx Pharmaceutical’s (RARE) share price is $46.69, making it a Sell.
Ultragenyx Pharmaceutical’s (RARE) 50-Day exponential moving average is 47.11, while Ultragenyx Pharmaceutical’s (RARE) share price is $46.69, making it a Sell.

Ultragenyx Pharmaceutical (RARE) Pivot Points

Apr 25, 2024, 02:26 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
44.24
44.89
45.86
46.51
47.47
48.12
49.09
Fibonacci
44.89
45.51
45.89
46.51
47.13
47.51
48.12
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ultragenyx Pharmaceutical (RARE) Moving Averages

Apr 25, 2024, 02:26 PM
Period
Simple
Exponential
MA5
46.05Buy
46.40Buy
MA10
46.49Buy
46.75Sell
MA20
48.37Sell
47.44Sell
MA50
47.24Sell
47.11Sell
MA100
44.93Buy
45.47Buy
MA200
42.29Buy
44.04Buy
Ultragenyx Pharmaceutical’s (RARE) 10-Day exponential moving average is 46.75, while Ultragenyx Pharmaceutical’s (RARE) share price is $46.69, making it a Sell.
Ultragenyx Pharmaceutical’s (RARE) 100-Day exponential moving average is 45.47, while Ultragenyx Pharmaceutical’s (RARE) share price is $46.69, making it a Buy.
Ultragenyx Pharmaceutical’s (RARE) stock price is $46.69 and Ultragenyx Pharmaceutical’s (RARE) 50-day simple moving average is 47.24, creating a Sell signal.
Ultragenyx Pharmaceutical’s (RARE) stock price is $46.69 and Ultragenyx Pharmaceutical’s (RARE) 100-day simple moving average is 44.93, creating a Buy signal.
Ultragenyx Pharmaceutical’s (RARE) stock price is $46.69 and Ultragenyx Pharmaceutical’s (RARE) 200-day simple moving average is 42.29, creating a Buy signal.

Ultragenyx Pharmaceutical (RARE) Technical Indicators

Apr 25, 2024, 02:26 PM
Name
Value
Implied Action
RSI (14)
45.74
Neutral
STOCH (9,6)
44.44
Neutral
STOCHRSI (14)
20.51
Neutral
MACD (12,26)
-0.63
Buy
ADX (14)
18.89
Buy
Williams %R
-71.72
Buy
CCI (14)
-55.63
Neutral
ATR (14)
1.61
-
Ultimate Oscillator
39.62
Neutral
ROC
-7.60
Sell
Ultragenyx Pharmaceutical’s (RARE) Relative Strength Index (RSI) is 45.74, creating a Neutral signal.
Ultragenyx Pharmaceutical’s (RARE) Trend Strength Indicator (ADX) is 18.89, creating a Buy signal.
Ultragenyx Pharmaceutical’s (RARE) Commodity Channel Index (CCI) is -55.63, creating a Neutral signal.
Ultragenyx Pharmaceutical’s (RARE) Price Rate of Change (ROC) is -7.60, creating a Sell signal.

FAQ

Is RARE a Buy, Hold, or Sell?
Based on RARE’s technical indicators, RARE is a Buy.
    What is RARE’s RSI (14)?
    RARE’s RSI (14) is 45.74, which suggests RARE is a Neutral.
      What is RARE’s MACD?
      RARE’s MACD is -0.63, which suggests RARE is a Buy.
        What is RARE’s 5-day moving average?
        RARE’s 5-day moving average is 46.05, which suggests RARE is a Buy.
          What is RARE’s 20-day moving average?
          RARE 20-day moving average is 48.37, which suggests RARE is a Sell.
            What is RARE’s 50-day moving average?
            RARE’s 50-day moving average is 47.24, which suggests RARE is a Sell.
              What is RARE’s 200-day moving average?
              RARE’s 200-day moving average is 42.29, which suggests RARE is a Buy.
                What is RARE’s Williams % R (14)?
                RARE’s Williams % R (14) is -71.72, which suggests RARE is a Buy.
                  What is RARE’s CCI (14)?
                  RARE’s CCI (14) is -55.63, which suggests RARE is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis